Encompass Health (EHC) Shares Outstanding (Weighted Average) (2009 - 2026)

Encompass Health has reported Shares Outstanding (Weighted Average) for 18 years, with the latest figure at $99.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 1.29% year-over-year to $99.2 million; the trailing twelve-month figure through Mar 2026 stood at $99.2 million (down 1.29% YoY), and the FY2025 full-year result was $100.5 million, up 0.6% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $99.2 million, down from $100.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $100.6 million in Q2 2025, with the low at $99.2 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $99.7 million across 5 years, with a median of $99.5 million in 2023.
• Annual changes were most pronounced in 2025 — Shares Outstanding (Weighted Average) advanced 0.7% — and 2026, when it slipped 1.29%.
• Encompass Health's Shares Outstanding (Weighted Average) stood at $99.2 million in 2022, then grew by 0.3% to $99.5 million in 2023, then grew by 0.4% to $99.9 million in 2024, then climbed by 0.6% to $100.5 million in 2025, then declined by 1.29% to $99.2 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $99.2 million (Q1 2026), $100.5 million (Q4 2025), and $100.5 million (Q3 2025), per Business Quant data.